Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|September 17, 2004
Remicade as TNF suppressor in patients with myelodysplastic syndromesA Raza, A Candoni, U Khan, et al.Journal of Medical Virology|August 10, 2020
Clinical and radiological diagnosis of non-SARS-CoV-2 viruses in the era of COVID-19 pandemicAylin O Alpaydin, Naciye S Gezer, Gokçen O Simsek, et al.Leukemia Research|August 11, 2000
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)H D Preisler, P Venugopal, S A Gregory, et al.Blood|August 9, 2001
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromesA Raza, P Meyer, D Dutt, et al.Leukemia Research|May 6, 1999
Biologic characteristics of patients with hypocellular myelodysplastic syndromesR Goyal, H Qawi, I Ali, et al.Blood|February 26, 2000
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasoneA Raza, H Qawi, L Lisak, et al.Leukemia Research|October 13, 2001
Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromesS Alvi, A Shaher, V Shetty, et al.International Journal of Hematology|June 1, 1996
Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokinesA Raza, S Mundle, V Shetty, et al.Leukemia Research|November 1, 1996
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromesV Shetty, S Mundle, S Alvi, et al.Leukemia|October 1, 1996
A paradigm shift in myelodysplastic syndromesA Raza, S Mundle, V Shetty, et al.Pageof 6